Israel Englander Genmab A/S Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Genmab A/S stock. As of the latest transaction made, Millennium Management LLC holds 473,929 shares of GMAB stock, worth $12.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

473,929

Previous 512,281 7.49%

Holding current value

$12.1 Million

Previous $16.3 Million 13.1%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$26.43 - $32.77 $1.01 Million - $1.26 Million	-38,352 Reduced 7.49%	473,929 $14.2 Million
Q4 2023 Feb 14, 2024	BUY	$27.94 - $35.44 $14.1 Million - $17.9 Million	504,500 Added 6483.74%	512,281 $16.3 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $11.2 Million - $12.8 Million	-298,641 Reduced 97.46%	7,781 $295,000
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $21.4 Million - $26.5 Million	-612,986 Reduced 66.67%	306,422 $11.6 Million
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $27 Million - $37.5 Million	797,770 Added 655.86%	919,408 $39 Million

Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $3.83 Million - $45.4 Million	121,638 New	121,638 $3.91 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $2.13 Million - $3.07 Million	-79,558 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $2.16 Million - $2.76 Million	-69,655 Reduced 46.68%	79,558 $2.88 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $4.98 Million - $6.55 Million	138,921 Added 1349.8%	149,213 $5.9 Million
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $427,632 - $501,426	10,292 New	10,292 $450,000
Q1 2021 May 17, 2021	SELL	$30.92 - $44.4 $503,346 - $722,787	-16,279 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$33.66 - $40.76 $2.67 Million - $3.23 Million	-79,315 Reduced 82.97%	16,279 $662,000
Q3 2020 Nov 16, 2020	SELL	$33.07 - $38.68 $5.31 Million - $6.21 Million	-160,506 Reduced 62.67%	95,594 $3.5 Million
Q2 2020 Aug 14, 2020	SELL	$20.05 - $33.89 $2.82 Million - $4.77 Million	-140,703 Reduced 35.46%	256,100 $8.68 Million
Q1 2020 May 14, 2020	BUY	$17.15 - $25.22 $5.91 Million - $8.69 Million	344,730 Added 662.01%	396,803 $8.41 Million
Q4 2019 Feb 14, 2020	SELL	$18.88 - $24.14 $4.91 Million - $6.28 Million	-260,282 Reduced 83.33%	52,073 $1.16 Million
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $5.62 Million - $6.68 Million	312,355 New	312,355 $6.33 Million

Others Institutions Holding GMAB

# of Institutions

241

Shares Held

47.6M

Call Options Held

31.3K

Put Options Held

38.7K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $16.8B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account